SF Insider Transaction: 15,000 Shares Sold; 32,919 Phantom Units Disclosed
Rhea-AI Filing Summary
David D. Sliney, Chief Operating Officer of Stifel Financial Corp. (SF), reported an insider sale on Form 4. The filing shows a disposition of 15,000 shares of Common Stock on 08/19/2025 at a price of $112.90 per share, leaving 156,043 shares beneficially owned after the transaction. The report also discloses 32,919 Phantom Stock Units held, which vest in 20% increments over five years and have no expiration date. The Form 4 was signed on 08/21/2025 and was filed by one reporting person.
Positive
- Clear disclosure of transaction date, price, and resulting beneficial ownership
- Detailed phantom unit information including vesting schedule and no expiration
- Form properly signed and filed by one reporting person, meeting filing formalities
Negative
- Insider sale of 15,000 shares reduced beneficial ownership
- No indication in the filing of a 10b5-1 plan or reason for the sale
Insights
TL;DR: Insider sale disclosed; routine transaction with clear post-sale ownership and phantom unit vesting details.
The Form 4 documents a straightforward sale of 15,000 common shares by the COO at $112.90 on 08/19/2025, leaving 156,043 shares beneficially owned. This filing provides explicit post-transaction holdings, helping investors assess insider liquidity and remaining exposure. The separate disclosure of 32,919 Phantom Stock Units and their vesting schedule clarifies future potential dilution or compensation-related issuance. No additional transactions, option exercises, or amendments are reported.
TL;DR: Disclosure meets Section 16 requirements and details compensation vesting; transaction appears routine.
The filing identifies the reporting person, role (Chief Operating Officer), and confirms a single reporting filer. It reports both the open-market sale and outstanding Phantom Stock Units with vesting terms (20% annually over five years) and no expiration, which is useful for governance transparency. The document contains no indication of planned trades under a Rule 10b5-1 plan or other atypical arrangements. The filing is complete for the disclosed items.